Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C
Most coinfected people with cirrhosis before HCV cure will remain cirrhotic. For those with significant fibrosis, regression can be expected within 2 years to levels not normally associated with an increased risk of end-stage liver disease. A TE measurement 2 years after cure should give a reliable estimate of residual fibrosis.
Authors
- Linda Wittkop (ORCID: https://orcid.org/0000-0003-2403-0960)
- Margaret Elena Hellard (ORCID: https://orcid.org/0000-0002-5055-3266)
- Marina B. Klein (ORCID: https://orcid.org/0000-0002-3063-8430)
- Rachel Sacks‐Davis (ORCID: https://orcid.org/0000-0003-0860-2762)
- Jim Young (ORCID: https://orcid.org/0000-0002-4314-3007)
- Juan Berenguer (ORCID: https://orcid.org/0000-0001-8541-8200)
- Ashleigh C. Stewart (ORCID: https://orcid.org/0000-0002-1399-3385)
- Joseph Doyle (ORCID: https://orcid.org/0000-0001-7198-0833)
- Gail Matthews (ORCID: https://orcid.org/0000-0002-1048-6396)
- Daniela K van Santen (ORCID: https://orcid.org/0000-0002-9890-4694)
- Karine Lacombe (ORCID: https://orcid.org/0000-0001-8772-9029)
- Mark A Stoove (ORCID: https://orcid.org/0000-0003-2887-1409)
- Shouao Wang
- Andri Rauch (ORCID: https://orcid.org/0000-0001-5297-6062)
- Marc van der Valk (ORCID: https://orcid.org/0000-0002-8290-6425)
Institutions
- University of Bern (CH)
- Burnet Institute (AU)
- Université de Bordeaux (FR)
- Inserm (FR)
- University Hospital of Bern (CH)
- McGill University Health Centre (CA)
- Hospital General Universitario Gregorio Marañón (ES)
- UNSW Sydney (AU)
- Sorbonne Université (FR)
- Monash Alfred Psychiatry Research centre (AU)
- Bordeaux Population Health (FR)
- Stichting HIV Monitoring (NL)
- Centre de Recherche Saint-Antoine (FR)
- Institute of Infection and Immunity (CA)
- HIV Legal Network (CA)
- McGill University (CA)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1097/qai.0000000000003646
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Bristol-Myers Squibb
- AstraZeneca
- Gilead Sciences
- Burnet Institute
- ViiV Healthcare
- Australian Government
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Ministerie van Volksgezondheid, Welzijn en Sport
- Ministerio de Ciencia e Innovación
- Canadian Institutes of Health Research
- Medical Research Council
- National Health and Medical Research Council
- Instituto de Salud Carlos III